193 related articles for article (PubMed ID: 22504523)
1. Shp2 function in hematopoietic stem cell biology and leukemogenesis.
Nabinger SC; Chan RJ
Curr Opin Hematol; 2012 Jul; 19(4):273-9. PubMed ID: 22504523
[TBL] [Abstract][Full Text] [Related]
2. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.
Xu D; Liu X; Yu WM; Meyerson HJ; Guo C; Gerson SL; Qu CK
J Exp Med; 2011 Sep; 208(10):1977-88. PubMed ID: 21930766
[TBL] [Abstract][Full Text] [Related]
3. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
Xu D; Wang S; Yu WM; Chan G; Araki T; Bunting KD; Neel BG; Qu CK
Blood; 2010 Nov; 116(18):3611-21. PubMed ID: 20651068
[TBL] [Abstract][Full Text] [Related]
4. Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival.
Yang Z; Li Y; Yin F; Chan RJ
Exp Hematol; 2008 Oct; 36(10):1285-96. PubMed ID: 18640765
[TBL] [Abstract][Full Text] [Related]
5. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
Chen L; Chen W; Mysliwski M; Serio J; Ropa J; Abulwerdi FA; Chan RJ; Patel JP; Tallman MS; Paietta E; Melnick A; Levine RL; Abdel-Wahab O; Nikolovska-Coleska Z; Muntean AG
Leukemia; 2015 Jun; 29(6):1290-300. PubMed ID: 25650089
[TBL] [Abstract][Full Text] [Related]
6. Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
Chan G; Kalaitzidis D; Usenko T; Kutok JL; Yang W; Mohi MG; Neel BG
Blood; 2009 Apr; 113(18):4414-24. PubMed ID: 19179468
[TBL] [Abstract][Full Text] [Related]
7. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
8. Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.
Mali RS; Ma P; Zeng LF; Martin H; Ramdas B; He Y; Sims E; Nabinger S; Ghosh J; Sharma N; Munugalavadla V; Chatterjee A; Li S; Sandusky G; Craig AW; Bunting KD; Feng GS; Chan RJ; Zhang ZY; Kapur R
Blood; 2012 Sep; 120(13):2669-78. PubMed ID: 22806893
[TBL] [Abstract][Full Text] [Related]
9. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.
Passegué E; Wagner EF; Weissman IL
Cell; 2004 Oct; 119(3):431-43. PubMed ID: 15507213
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia.
Xu R; Yu Y; Zheng S; Zhao X; Dong Q; He Z; Liang Y; Lu Q; Fang Y; Gan X; Xu X; Zhang S; Dong Q; Zhang X; Feng GS
Blood; 2005 Nov; 106(9):3142-9. PubMed ID: 16030196
[TBL] [Abstract][Full Text] [Related]
11. The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.
Nabinger SC; Li XJ; Ramdas B; He Y; Zhang X; Zeng L; Richine B; Bowling JD; Fukuda S; Goenka S; Liu Z; Feng GS; Yu M; Sandusky GE; Boswell HS; Zhang ZY; Kapur R; Chan RJ
Leukemia; 2013 Feb; 27(2):398-408. PubMed ID: 23103841
[TBL] [Abstract][Full Text] [Related]
12. Role of SHP2 in hematopoiesis and leukemogenesis.
Pandey R; Saxena M; Kapur R
Curr Opin Hematol; 2017 Jul; 24(4):307-313. PubMed ID: 28306669
[TBL] [Abstract][Full Text] [Related]
13. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
[TBL] [Abstract][Full Text] [Related]
14. Kit and Scl regulation of hematopoietic stem cells.
Rojas-Sutterlin S; Lecuyer E; Hoang T
Curr Opin Hematol; 2014 Jul; 21(4):256-64. PubMed ID: 24857885
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia.
Konieczna I; Horvath E; Wang H; Lindsey S; Saberwal G; Bei L; Huang W; Platanias L; Eklund EA
J Clin Invest; 2008 Mar; 118(3):853-67. PubMed ID: 18246201
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic colony formation from human growth factor-dependent TF1 cells and human cord blood myeloid progenitor cells depends on SHP2 phosphatase function.
Broxmeyer HE; Etienne-Julan M; Gotoh A; Braun SE; Lu L; Cooper S; Feng GS; Li XJ; Chan RJ
Stem Cells Dev; 2013 Mar; 22(6):998-1006. PubMed ID: 23082805
[TBL] [Abstract][Full Text] [Related]
17. Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.
Zhu HH; Ji K; Alderson N; He Z; Li S; Liu W; Zhang DE; Li L; Feng GS
Blood; 2011 May; 117(20):5350-61. PubMed ID: 21450902
[TBL] [Abstract][Full Text] [Related]
18. Activating mutations in protein tyrosine phosphatase Ptpn11 (Shp2) enhance reactive oxygen species production that contributes to myeloproliferative disorder.
Xu D; Zheng H; Yu WM; Qu CK
PLoS One; 2013; 8(5):e63152. PubMed ID: 23675459
[TBL] [Abstract][Full Text] [Related]
19. Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants.
Yang Z; Kondo T; Voorhorst CS; Nabinger SC; Ndong L; Yin F; Chan EM; Yu M; Würstlin O; Kratz CP; Niemeyer CM; Flotho C; Hashino E; Chan RJ
Mol Cell Biol; 2009 Aug; 29(16):4376-93. PubMed ID: 19528235
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia.
Zhang W; Chan RJ; Chen H; Yang Z; He Y; Zhang X; Luo Y; Yin F; Moh A; Miller LC; Payne RM; Zhang ZY; Fu XY; Shou W
J Biol Chem; 2009 Aug; 284(33):22353-22363. PubMed ID: 19509418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
